leronlimab vs placebo -- nah, just more poorly wor
Post# of 148251
(Total Views: 381)
Posted On: 05/25/2021 2:25:08 PM
leronlimab vs placebo -- nah, just more poorly worded documents-gives us something to do here...
"This is a Phase 3, 2-arm, randomized, double blind, placebo controlled, multicenter study to evaluate the safety and efficacy of leronlimab (PRO 140) as an add on therapy to the institutional standard of care (SoC) for the management of critically ill patients with COVID-19 pneumonia."
"This is a Phase 3, 2-arm, randomized, double blind, placebo controlled, multicenter study to evaluate the safety and efficacy of leronlimab (PRO 140) as an add on therapy to the institutional standard of care (SoC) for the management of critically ill patients with COVID-19 pneumonia."
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼